HomeLABB • BMV
add
Genomma Lab Internacional SAB de CV
Nakaraang pagsara
$17.31
Sakop ng araw
$16.70 - $17.44
Sakop ng taon
$15.89 - $25.48
Market cap
16.83B MXN
Average na Volume
2.54M
P/E ratio
10.24
Dividend yield
4.76%
Primary exchange
BMV
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (MXN) | Mar 2026info | Y/Y na pagbabago |
|---|---|---|
Kita | 4.19B | -4.90% |
Gastos sa pagpapatakbo | — | — |
Net na kita | — | — |
Net profit margin | 11.80 | 4.24% |
Kita sa bawat share | 0.49 | -2.00% |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (MXN) | Mar 2026info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | — | — |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | — | — |
Natitirang share | — | — |
Presyo para makapag-book | — | — |
Return on assets | 8.99% | — |
Return on capital | 11.37% | — |
Cash Flow
Net change in cash
| (MXN) | Mar 2026info | Y/Y na pagbabago |
|---|---|---|
Net na kita | — | — |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Genomma Lab Internacional or simply Genomma Lab is a Mexican company, founded in 1996, dedicated to the commercialization of OTC medications and dermocosmetic products. It is part of the Índice de Precios y Cotizaciones, the main stock index of the Mexican Stock Exchange. It is one of the leading pharmaceutical companies in the country.
Genomma Lab Internacional, led by its owner Rodrigo Alonso Herrera Aspra, recorded net sales of 9,799.7 million Mexican pesos, equivalent to 756.0 million USD in 2012, achieving a 21.6% growth compared to 2011. Currently, Genomma Lab operates in 15 countries outside Mexico and has achieved success by replicating its business model. Wikipedia
Itinatag
1996
Website
Mga Empleyado
1,643
